Научные публикации

Arvenacogene sanparvovec: A novel gene therapy for hemophilia B – results from A phase I–II first-in-human trial

Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial


Lev Demidov, Igor Samoylenko, Galina Kharkevich, Kristina Orlova, Vladimir Moiseenko, Igor Utyashev, Daniil Stroyakovskiy, Vadim Kozlov, Anastasia Zimina, Anastasia Mochalova, Svetlana Demidova, Marina Lyadova, Andrey Kutkovich, Pavel Skopin, Nadezhda Kovalenko, Sufia Safina, Vitaliy Volkov, Yulia Semiletova, Vera Vaschenko, Nikolay Kislov, Artem Poltoratskiy, Irina Shumskaya, Sergey Kolomiets, Alexandr Sobolev, Igor Belogortsev, Svetlana Odintsova, Sameer Rastogi, Timur Andabekov, Konstantin Penkov, Anna Semenova, Alexey Obukhov, Vasiliy Belyakovsky, Alexander Yurchenkov, Oleg Gladkov, Rakesh Neve, Natalia Falaleeva, Elena Poddubskaya, Amale Vaibhav, Dmitriy Kirtbaya, Yana Chapko, Maria Smagina, Natalya Fadeeva, Irina Sorokina, Evgenia Mikhailova, Yulia Linkova, Arina Zinkina-Orikhan, Anton Lutskii, Rishat Gabidullin, Roman Rzaev, Fedor Kryukov

Стероид-сберегающее действие левилимаба при ревматоидном артрите в реальной практике

Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer

K. Laktionova A. Smolinb D. Stroyakovskiyc V. Moiseenkod M. Dvorkine T. Andabekovf Y. Chengg B. Liuh V. Kozlovi S. Odintsovaj S. Dvoretskyk A. Mochaloval M. Urdam T. Yin X. Lio U. Lászlóp V. Müllerq K. Bogosr N. Fadeevas G. Musaevt Q. Liuu D. Kirtbayav J. Shiw O. Gladkovx M. Narimanovy T. Semiglazovaz A. Khasanovaaa J. Chovanecab I. Andrašinaac ∙ A. Szabováad ∙ O. Rosinskáae ∙ D. Sudekovaaf ∙ P.-S. Zsoltag F. Ranah M. Sunai O. Jiangaj R. Chenak E. Zhaoal C. Liuam W. Tanan A. Pirmagomedovao E. Poddubskayaap N. Kislovaq I. Shumskayaar I. Sorokinaas A. Zinkina-Orikhanas Yu. Linkovaas S. Fogtas D. Liaptsevaas A. Siliutinaas O. Basovaas F. Kryukov